Follow CGSP on Social Media

Listen to the CGSP Podcast

Concerns Over Sinopharm’s Efficacy Prompts Some in UAE to Over-Vaccinate

Reports that the Chinese-made Sinopharm COVID-19 vaccine may be faltering against the onslaught of the Delta variant is prompting some in countries like the United Arab Emirates to re-vaccinate using a stronger vaccine-like Pfizer’s.

But UAE public health officials are strenuously warning people to not do that given that it could lead to adverse health consequences. “We note that some people may insist on taking more doses of the Covid-19 vaccine than recommended, which contradicts the opinion of doctors, and which may expose them to unwanted health complications,” the National Emergency Crisis and Disasters Management Authority said.

Lead the Conversation on China

Subscribe Today to Get Full Access to The China-Global South Project

Check Out Everything You'll Get With Your Subscription

The China-Global South Daily Brief delivered to your inbox at 6AM Washington time

Full access to exclusive news and analysis from editors based in the Global South

Transcripts of CGSP’s twice-weekly podcasts

Students and teachers with a valid .edu email address are eligible for a 50% discount off monthly or yearly subscriptions. Email us to receive a discount code.

What is The China-Global South Project?


The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.